Stevanato Group S.p.A., a global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life science industries, has appointed Ugo Gay as its new Chief Operations Officer (COO).
 
Gay offers nearly three decades of experience in industry, business management, supply chain, and operations. Before joining Stevanato Group, he held key leadership positions at renowned organizations, including the Biological Chemotherapy Institute of Turin and Diasorin, an Italian multinational biotechnology company. At Diasorin, Gay served in various roles, from Sales to Industrial Operations, culminating in his tenure as CEO and General Manager of the new subsidiary Diasorin Italia S.p.A.
 
In his new role as COO of Stevanato Group, Gay will shape and execute sourcing, planning, and manufacturing strategies to help drive the Company’s growth and achieve its business goals and vision. With a focus on maximizing returns on investments and driving efficiencies, Ugo will oversee priority strategic projects and lead the development and management of information systems to support the Company’s development and standardization of processes.
 
“We are thrilled to welcome Ugo Gay to our leadership team,” said Franco Moro, CEO at Stevanato Group. “Ugo’s wealth of experience and proven track record in driving operational excellence and growth will be invaluable as we continue to expand and innovate in the pharma, biopharma, and life science sectors. His appointment reflects our commitment to building a world-class team capable of delivering sustainable success.”
 
“I am honored to help lead Stevanato Group’s journey towards operational excellence, driving sustainable growth across our global footprint while fostering innovation,” Gay remarked.